Mesenchymal stem cells are multipotent adult stem cells that are present in multiple tissues, including umbilical cord, bone marrow and fat tissue. Mesenchymal stem cells can self-renew by ...
The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...
The homegrown therapy is the first mesenchymal stromal cell treatment that has gained the green light on the Chinese mainland. The approval was issued through an accelerated market registration ...
The homegrown therapy is the first mesenchymal stromal cell treatment that has gained the greenlight on the Chinese mainland. The approval was issued through an accelerated market registration ...